Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nerve endings in the colonic mucosa comprise the terminal arborizations of extrinsic (spinal and vagal sensory) and intrinsic (enteric) neurons that detect mechanical, chemical, and noxious stimuli. These terminals play key roles in the transduction of luminal contents, regulation of local secretion, motility, and sensation—including visceral pain—by sending signals to the spinal cord (via dorsal root ganglia) or integrating within enteric neuronal circuits of the submucosal and myenteric plexuses. They include peptidergic (CGRP-positive) and nonpeptidergic classes, form terminal fields within crypts, ganglia, and muscular layers, and are modulated by various neurotransmitters and ion channels (e.g., acetylcholine, VIP, CGRP, TRPV1, ASIC3). These structures are implicated in bowel dysfunctions, pain syndromes, and inflammatory bowel diseases. However, "nerve endings in the colonic mucosa" is not a specific molecular target but an anatomical descriptor of a diverse population of nerve terminals[1][2][3][4][5][6][7][8].\n\nSummary:\nThis is not a canonical therapeutic target but an anatomical/functional descriptor encompassing diverse neuronal structures that cannot be captured as a single molecular entity. For structured drug or target research, focus on specific ion channels (TRPV1, ASIC3), neurotransmitter receptors, or defined neuron classes within the colonic mucosa.
Ion channel blockade/activation (e.g. TRPV1, ASIC3 modulating mechanosensory afferent activity)\nNeurotransmitter modulation (cholinergic, noncholinergic mechanisms affecting gut functions)\nModulation of local signaling (immune, endocrine, or reflex regulation)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nerve ending in the colonic mucosa.